Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၁.၈၀%
၁,၀၄၇.၀၀
-၁၉.၂၁
-၁.၈၀%
—၁,၀၆၆.၂၁၁,၀၆၄.၉၄၁,၀၆၄.၉၄၁,၀၃၈.၇၇——
SIXC
Communications
SIXC
Communications
SIXC
-၀.၈၈%
၆၀၅.၈၀
-၅.၃၆
-၀.၈၈%
—၆၁၁.၁၆၆၁၁.၁၆၆၁၂.၂၅၆၀၅.၃၆——
SIXE
Energy
SIXE
Energy
SIXE
+၀.၇၅%
၁,၂၇၉.၄၂
+၉.၄၉
+၀.၇၅%
—၁,၂၆၉.၉၃၁,၂၇၃.၁၆၁,၂၈၀.၂၇၁,၂၆၂.၆၉——
SIXI
Industrials
SIXI
Industrials
SIXI
-၀.၇၈%
၁,၇၀၇.၀၅
-၁၃.၃၆
-၀.၇၈%
—၁,၇၂၀.၄၁၁,၇၁၇.၃၉၁,၇၁၇.၃၉၁,၆၉၄.၄၇——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၄၀%
၆၃၄.၅၆
-၂.၅၇
-၀.၄၀%
—၆၃၇.၁၃၆၃၇.၄၀၆၃၇.၇၄၆၃၁.၇၇——
SIXR
Staples
SIXR
Staples
SIXR
+၀.၄၉%
၈၇၀.၄၆
+၄.၂၁
+၀.၄၉%
—၈၆၆.၂၅၈၆၅.၇၇၈၇၄.၁၂၈၅၈.၇၂——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+၀.၄၂%
၂၁၅.၅၄
+၀.၉၀
+၀.၄၂%
—၂၁၄.၆၄၂၁၄.၆၄၂၁၅.၉၇၂၁၃.၄၉——
SIXT
Technology
SIXT
Technology
SIXT
-၀.၃၆%
၃,၄၉၈.၄၇
-၁၂.၆၆
-၀.၃၆%
—၃,၅၁၁.၁၃၃,၄၈၁.၀၇၃,၅၂၇.၅၉၃,၄၄၀.၂၀——
SIXU
Utilities
SIXU
Utilities
SIXU
+၀.၈၉%
၈၉၄.၈၅
+၇.၉၃
+၀.၈၉%
—၈၈၆.၉၂၈၈၅.၂၃၈၉၅.၉၁၈၈၁.၇၄——
SIXV
Health care
SIXV
Health care
SIXV
+၁.၂၂%
၁,၄၈၈.၃၆
+၁၇.၈၇
+၁.၂၂%
—၁,၄၇၀.၄၉၁,၄၇၀.၆၈၁,၄၉၄.၄၂၁,၄၆၂.၁၆——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-၁.၅၉%
၂,၃၁၂.၃၇
-၃၇.၄၀
-၁.၅၉%
—၂,၃၄၉.၇၇၂,၃၃၂.၁၇၂,၃၃၂.၁၇၂,၃၀၇.၄၃——
VWIAX:MUTF
Vanguard Wellesley® Income Fund Admiral™ Shares
၆၂.၃၇ US$
+၀.၃၂%
(+၀.၂၀) 1D
မေ ၁၈, UTC ၀၀:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VWIAX...
Previous close
၆၂.၁၇ US$
Yield
၃.၅၁%
Expense ratio
၀.၁၅%
Net assets
ဋေ ၄.၀၅ ထ USD
Morningstar rating
★★★☆☆
Category
Cautious Allocation
Inception date
၂၀၀၁ မေ ၁၄
News stories
From sources across the web
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၅ မိနစ်
Akamai Technologies (NASDAQ:AKAM) Shares Gap Down - Time to Sell?
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၁၅ မိနစ်
S&P 500 Earnings Growth Tempered With One-Time Gains And The Treasury Yield Curve
ChartMill
ChartMill
·
ပြီးခဲ့သည့် ၁၅ မိနစ်
Tuesday's session: top gainers and losers in the S&P500 index
FinancialContent
FinancialContent
·
ပြီးခဲ့သည့် ၂၅ မိနစ်
FinancialContent - Acurx Pharmaceuticals (NASDAQ: ACXP) Highlights FDA's New CDI Guidance That Could Accelerate Approval Path for Ibezapolstat
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer